BlackRock
CGTX icon

BlackRock’s Cognition Therapeutics CGTX Stock Holding History

BlackRock’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$735K Sell
968,362
-45,976
-5% -$53.5K ﹤0.01% 4426
2025
Q4 		$1.37M Buy
1,014,338
+45,639
+5% +$74.1K ﹤0.01% 4221
2025
Q3 		$1.31M Buy
968,699
+891,844
+1,160% +$1.22M ﹤0.01% 4210
2025
Q2 		$23.8K Sell
76,855
-77,702
-50% -$26.2K ﹤0.01% 5120
2025
Q1 		$65K Sell
154,557
-1,482
-0.9% -$871 ﹤0.01% 4865
2024
Q4 		$109K Buy
156,039
+494
+0.3% +$244 ﹤0.01% 4770
2024
Q3 		$72.9K Buy
155,545
+2,964
+2% +$3.06K ﹤0.01% 4731
2024
Q2 		$253K Buy
152,581
+96,761
+173% +$193K ﹤0.01% 4502
2024
Q1 		$102K Buy
55,820
+211
+0.4% +$436 ﹤0.01% 4723
2023
Q4 		$103K Sell
55,609
-624
-1% -$825 ﹤0.01% 4794
2023
Q3 		$81K Sell
56,233
-2,184
-4% -$3.42K ﹤0.01% 4907
2023
Q2 		$107K Buy
58,417
+20,678
+55% +$43.8K ﹤0.01% 4893
2023
Q1 		$74.7K Buy
37,739
+1,122
+3% +$2.14K ﹤0.01% 5040
2022
Q4 		$76.9K Buy
36,617
+6,812
+23% +$13.8K ﹤0.01% 5118
2022
Q3 		$56K Buy
29,805
+2,296
+8% +$4.78K ﹤0.01% 5330
2022
Q2 		$58K Buy
27,509
+19,224
+232% +$49.7K ﹤0.01% 5379
2022
Q1 		$23K Buy
8,285
+288
+4% +$1.11K ﹤0.01% 5543
2021
Q4 		$51K Buy
+7,997
New +$78K ﹤0.01% 5395

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock's CGTX Position: Q1 2026 in Review

BlackRock reduced its Cognition Therapeutics (CGTX) stake by 4.5% in Q1 2026, selling an estimated $53.5K and leaving 968,362 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #4426.

BlackRock first reported a position in CGTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.37M in Q4 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • BlackRock held 968,362 shares of Cognition Therapeutics worth $735K as of Q1 2026.
  • BlackRock sold 45,976 Cognition Therapeutics shares in Q1 2026, an estimated $53.5K.
  • Cognition Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4426 holding.
  • BlackRock first reported a position in Cognition Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • BlackRock's Cognition Therapeutics position peaked at $1.37M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.